Versantis AG

Versantis develops a new generation of effective medicines and reliable diagnostics to revolutionize the care of patients with liver disease. Its lead candidate, VS-01, has the potential to fill the medical gap between preventive drugs and liver transplantations, and received Orphan Drug Designations from both the FDA and EMA. With a pipeline embracing a broad range of indications, Versantis aims to answer the unmet medical need of millions of people worldwide.

Versantis raised a CHF 4.4M series A in 2017 and has been rewarded with the most prestigious scientific and entrepreneurial prizes.

Job Offers

Chief Medical Officer

Versantis AGZürich

26/04/2018Executive po­si­tion
Gefunden auf versantis.ch

Reviews

No reviews yet
Help other job seekers and be the first one to write a review.

Location

Versantis AG

Otto-Stern-Weg 7
8093 Zürich

http://www.versantis.ch/

This website uses cookies to ensure you receive the best service. Further information can be found in our Terms and Conditions and in the Privacy Policy.